ClinConnect ClinConnect Logo
Search / Trial NCT02330224

Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health

Launched by DUKE-NUS GRADUATE MEDICAL SCHOOL · Dec 31, 2014

Trial Information

Current as of May 02, 2025

Completed

Keywords

Blood Pressure Lipids Cardiovascular Health Services Hypertension

ClinConnect Summary

1. Background:

Cardiovascular diseases (CVD) are the leading cause of disability and death in Singapore, and consume substantial healthcare resources. Uncontrolled hypertension confers the highest attributable risk of CVD. About one in four adults suffer from hypertension in Singapore, 50% of them have uncontrolled blood pressure (BP), and management is especially sub-optimal among those with concomitant diabetes or dyslipidemia. Evidence suggests that well structured programs of care delivery are effective in lowering BP and preventing CVD. However, there is lack of empirical data on s...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 40 years or older
  • Singapore citizen and Permanent Resident
  • Individuals visiting the recruiting polyclinic at least twice during the last 1 year
  • Individuals with with previously diagnosed hypertension and uncontrolled blood pressure (Systolic BP 140 mmHg and above and diastolic BP 90 mmHg)
  • Exclusion Criteria:
  • Individuals with active systemic illness including fever
  • Individuals with recent hospitalization (i.e. during last 4 months),
  • Individuals with clinically unstable heart failure (i.e. Ejection fraction \<20% or complaint of shortness of breath at rest)
  • Individuals with advanced kidney disease (i.e. estimated Chronic kidney disease (CKD) -Epi glomerular filtration rate \<40 ml/min/1.73m2 or nephrotic range proteinuria (i.e. 3g/d or more))
  • Individuals with known advanced liver disease (i.e. Child-Pugh Stage C)
  • Individuals with pregnancy
  • Individuals with any other major debilitating disease or
  • Individuals with mental illness that precludes validity of informed consent

About Duke Nus Graduate Medical School

Duke-NUS Graduate Medical School is a leading biomedical research institution located in Singapore, renowned for its commitment to advancing medical education, research, and healthcare innovation. As a partnership between Duke University in the United States and the National University of Singapore, the school emphasizes a collaborative approach to tackling pressing health challenges through cutting-edge clinical trials and interdisciplinary research. With a focus on translating scientific discoveries into practical applications, Duke-NUS plays a pivotal role in shaping the future of medicine and healthcare in the region and beyond.

Locations

Singapore, , Singapore

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Tazeen H Jafar, MD, MPH

Principal Investigator

Duke-NUS Graduate Medical School

Ngiap Chuan Tan, MBBS

Principal Investigator

SingHealth Polyclinics, Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials